Coagulation factor XIII: An unrecognized regulator of fibrinolytic phenotypes in trauma—A potential link to cysteine cathepsin degradation of plasminogen
Authors:
- Peter K. MoorePMPeter K. Moore
- Ernest E. MooreEMErnest E. Moore
- Raleigh GarnerRGRaleigh Garner
- Kirk HansenKHKirk Hansen
- Christopher D. BarrettCBChristopher D. Barrett
- Angela SauaiaASAngela Sauaia
- James ChandlerJCJames Chandler
- William J. JanssenWJWilliam J. Janssen
- Hunter B. MooreHMHunter B. Moore
- 25 July 2025
- journal article
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 100 (2) , 271-280
Abstract
BACKGROUND: Trauma-induced coagulopathy (TIC) has distinct fibrinolytic phenotypes based on viscoelastic testing. The underlying mechanisms behind differences in fibrinolytic responses to trauma are unclear. We hypothesized that plasma proteins crosslinked into fibrin clots by the transglutaminase activity of factor XIII (FXIII) may explain tissue-type plasminogen activator (tPA) responsiveness observed in fibrinolysis shutdown. METHODS: Plasma samples from trauma patients were categorized into four fibrinolytic phenotypes (hyperfibrinolysis, hypofibrinolysis, fibrinolysis shutdown, and physiologic fibrinolysis) based on rapid thromboelastography and tPA-enhanced thromboelastography. Plasma underwent liquid chromatography–mass spectrometry proteomics for substrates of FXIII, evaluation for FXIII concentration/activity, and Western blotting to confirm proteomic findings. In vitro studies assessed cysteine cathepsin-mediated proteolysis of fibrinolytic and clot-related proteins. RESULTS: Plasma proteomic analysis identified differences in levels of four proteins known to be crosslinked into fibrin in fibrinolysis shutdown patients. Patients with shutdown exhibited significantly higher plasma FXIII activity compared with other phenotypes. Because FXIII crosslinks protease inhibitors to fibrin, we studied inflammatory cysteine cathepsins' ability to degrade fibrinolytic proteins. Cysteine cathepsins degraded coagulation and fibrinolytic proteins in vitro, including plasminogen, tPA, and fibrinogen. Cathepsin L exposure completely disrupted ex vivo fibrin clot formation and impaired fibrinolytic enzyme function, highlighting its potential multifaceted role in TIC pathophysiology. CONCLUSION: Elevated FXIII activity and protease inhibitor incorporation into fibrin clots may regulate fibrinolysis shutdown in trauma patients with fibrinolysis shutdown by inhibiting cysteine cathepsin activity. These findings identify FXIII and cysteine cathepsins as possible contributors to TIC that should be studied further.Keywords
This publication has 28 references indexed in Scilit:
- Neutrophil-Mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural FibrinolysisChest, 2024
- Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic StatesSeminars in Thrombosis and Hemostasis, 2022
- Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potentialMolecular Aspects of Medicine, 2022
- Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?Journal of the American College of Surgeons, 2019
- Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trialThe Lancet, 2018
- Exploring ethical conflicts in emergency trauma research: The COMBAT (Control of Major Bleeding after Trauma) study experienceSurgery, 2015
- Factor XIIIA Transglutaminase Crosslinks AT1 Receptor Dimers of Monocytes at the Onset of AtherosclerosisCell, 2004
- A Microtiter Assay for Factor XIII Using Fibrinogen and Biotinylcadaverine as SubstratesAnalytical Biochemistry, 1994
- Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).Journal of Biological Chemistry, 1991
- Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.Journal of Biological Chemistry, 1982